Differed IL-1 Beta Response between Active TB and LTBI Cases by Ex Vivo Stimulation of Human Monocyte-Derived Macrophage with TB-Specific Antigen. (29th October 2019)
- Record Type:
- Journal Article
- Title:
- Differed IL-1 Beta Response between Active TB and LTBI Cases by Ex Vivo Stimulation of Human Monocyte-Derived Macrophage with TB-Specific Antigen. (29th October 2019)
- Main Title:
- Differed IL-1 Beta Response between Active TB and LTBI Cases by Ex Vivo Stimulation of Human Monocyte-Derived Macrophage with TB-Specific Antigen
- Authors:
- Lee, Meng-Rui
Chang, Lih-Yu
Chang, Chia-Hao
Yan, Bo-Shiun
Wang, Jann-Yuan
Lin, Wan-Hsin - Other Names:
- Harangi Mariann Academic Editor.
- Abstract:
- Abstract : Background . The difference of macrophage-specific interleukin-1 beta (IL-1b) response between latent tuberculosis infection (LTBI) and active tuberculosis (TB) remains less studied. Method . We performed this prospective study and recruited active TB patients, contacts with LTBI, and uninfected contacts. The gene and protein expression of human monocyte-derived macrophage (hMDM) after ex vivo stimulation by early secretory antigenic target-6KD (ESAT-6) and tuberculin purified protein derivatives (PPD) was studied by real-time PCR and flow cytometry. The effect of caspase-1 inhibitor was also studied. Result . The IL-1b gene expression after 6 hr ESAT-6 1 μ g/ml stimulation was different among active TB patients (n = 12 ), LTBI cases (n = 12 ), and uninfected contacts (n = 23 ) (log fold change: 0.98 ± 1.26 vs. 2.20 ± 0.96 vs. 2.20 ± 0.96, P = 0.013 ). The IL-1b gene expression at 24 hours was higher than that at 6 hours in LTBI cases (n = 4 ) and uninfected contacts (n = 6 ). After 24 hr ESAT-6 1 μ g/ml stimulation, the percentage of IL-1b-expressed hMDM was borderline lower in the active TB patients (n = 9 ) than in the LTBI cases (n = 10 ) (14.0 ± 11.2 % vs. 31.6 ± 22.5 %, P = 0.065 ). Compared with ESAT-6 1 μ g/ml stimulation but without the addition of caspase-1 inhibitor (CasI) (55.6 ± 16.3 % ), the percentage of IL-1b-positive hMDMs decreased after addition of CasI (50 μ g/ml CasI: 49.8 ± 18.2 %, P = 0.078 ; 100 μ g/ml CasI: 46.6 ± 20.8 %, P = 0.030 ;Abstract : Background . The difference of macrophage-specific interleukin-1 beta (IL-1b) response between latent tuberculosis infection (LTBI) and active tuberculosis (TB) remains less studied. Method . We performed this prospective study and recruited active TB patients, contacts with LTBI, and uninfected contacts. The gene and protein expression of human monocyte-derived macrophage (hMDM) after ex vivo stimulation by early secretory antigenic target-6KD (ESAT-6) and tuberculin purified protein derivatives (PPD) was studied by real-time PCR and flow cytometry. The effect of caspase-1 inhibitor was also studied. Result . The IL-1b gene expression after 6 hr ESAT-6 1 μ g/ml stimulation was different among active TB patients (n = 12 ), LTBI cases (n = 12 ), and uninfected contacts (n = 23 ) (log fold change: 0.98 ± 1.26 vs. 2.20 ± 0.96 vs. 2.20 ± 0.96, P = 0.013 ). The IL-1b gene expression at 24 hours was higher than that at 6 hours in LTBI cases (n = 4 ) and uninfected contacts (n = 6 ). After 24 hr ESAT-6 1 μ g/ml stimulation, the percentage of IL-1b-expressed hMDM was borderline lower in the active TB patients (n = 9 ) than in the LTBI cases (n = 10 ) (14.0 ± 11.2 % vs. 31.6 ± 22.5 %, P = 0.065 ). Compared with ESAT-6 1 μ g/ml stimulation but without the addition of caspase-1 inhibitor (CasI) (55.6 ± 16.3 % ), the percentage of IL-1b-positive hMDMs decreased after addition of CasI (50 μ g/ml CasI: 49.8 ± 18.2 %, P = 0.078 ; 100 μ g/ml CasI: 46.6 ± 20.8 %, P = 0.030 ; 150 μ g/ml CasI: 33.7 ± 15.5 %, P = 0.016 ). Conclusions . This study revealed that macrophage-specific IL-1b response differed among different stages of Mycobacterium tuberculosis infection. The role of IL-1b and inflammasome in the process of LTBI progressing to active TB warrants further investigation. … (more)
- Is Part Of:
- Disease markers. Volume 2019(2019)
- Journal:
- Disease markers
- Issue:
- Volume 2019(2019)
- Issue Display:
- Volume 2019, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 2019
- Issue:
- 2019
- Issue Sort Value:
- 2019-2019-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-10-29
- Subjects:
- Diagnosis -- Periodicals
Biochemical markers -- Periodicals
Pathology -- Periodicals
616 - Journal URLs:
- https://www.hindawi.com/journals/dm/ ↗
- DOI:
- 10.1155/2019/7869576 ↗
- Languages:
- English
- ISSNs:
- 0278-0240
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 12153.xml